RFA-DA-22-006 - High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Special Interest (NOSI): Leveraging transformative connectome resources in model organisms to elucidate the neurobiology of substance use disorders NOT-DA-21-006 NIDA Apr 30, 2021 Sep 8, 2024 R01, R03, R21, 333

For technical issues E-mail OER Webmaster